Anthem Biosciences: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

Anthem Biosciences Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from January 01, 2026, and will remain in effect unti...

Anthem Biosciences Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from January 01, 2026, and will remain in effect until 48 hours after the Board Meeting where the financial results for the quarter ending December 31, 2025, are approved. All designated persons within the company have been duly informed and are prohibited from trading in the company's securities during this period. The specific date for the Board Meeting to approve the financial results will be communicated to the stock exchanges in due course. The company has also provided its BSE Scrip Code (544449) and NSE Scrip Symbol (ANTHEM) for reference.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Anthem Biosciences Limited in the news today?

Anthem Biosciences Limited (ANTHEM) is in the news due to the announcement is a routine regulatory disclosure regarding the closure of the trading window and does not contain any specific financial performance data or significant corporate actions that would positively or negatively impact the company's outlook.

Trading Window DisclosureInsider Trading
Anthem Biosciences LimitedANTHEMhttps://prysm.fi/v2/analyze/ANTHEM

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Anthem Biosciences: Trading Window Closed Jan 1, 2026 for Q3 FY26 Results

December 29, 2025, 11:02 AM

AI Sentiment Analysis

Top Queries to Ask About Anthem Biosciences Limited

Anthem Biosciences Limited has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from January 01, 2026, and will remain in effect until 48 hours after the Board Meeting where the financial results for the quarter ending December 31, 2025, are approved.

All designated persons within the company have been duly informed and are prohibited from trading in the company's securities during this period. The specific date for the Board Meeting to approve the financial results will be communicated to the stock exchanges in due course.

The company has also provided its BSE Scrip Code (544449) and NSE Scrip Symbol (ANTHEM) for reference.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Anthem Biosciences Limited

Discover more trending news on Prysm

View All